drugset / Trial / NCT00346658
Magnesium Supplementation to Prevent Bone Loss
Phase 1
Completed
74 enrolled
University of Tennessee
National Center for Research Resources (NCRR) · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
Extreme magnesium deficiency is known to have an impact on the synthesis, secretion and/or action of calcium regulating hormones. Many older adults are at risk for less severe magnesium deficiency, since the majority of adults receive less than the Recommended Daily Allowance of magnesium. We hypothesize that magnesium supplementation will have a beneficial effect on calcium regulating hormones and markers of bone turnover.
Timeline
- Start
- 2002-07
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 250 mg | — |